242 related articles for article (PubMed ID: 2544787)
1. Augmentation of helper virus replication in the presence of defective retrovirus.
Anand R; Steeves RA; Lilly F
Microbios; 1989; 58(235):71-82. PubMed ID: 2544787
[TBL] [Abstract][Full Text] [Related]
2. Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of Friend virus complex.
Lu L; Hangoc G; Oliff A; Chen LT; Shen RN; Broxmeyer HE
Cancer Res; 1987 Aug; 47(15):4184-8. PubMed ID: 3038309
[TBL] [Abstract][Full Text] [Related]
3. Helper-dependent properties of Friend spleen focus-forming virus: effect of the Fv-1 gene on the late stages in virus synthesis.
Eckner RJ
J Virol; 1973 Sep; 12(3):523-33. PubMed ID: 4127030
[TBL] [Abstract][Full Text] [Related]
4. Friend erythroleukemia virus complex: role of viral components in modifying erythroid differentiation in mice.
Fagg B; Ostertag W
J Natl Cancer Inst; 1982 Mar; 68(3):457-60. PubMed ID: 6950173
[TBL] [Abstract][Full Text] [Related]
5. Defective Friend spleen focus-forming virus: interfering properties and isolation free from standard leukemia-inducing helper virus.
Eckner RJ; Hettrick KL
J Virol; 1977 Oct; 24(1):383-96. PubMed ID: 904028
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of human lactoferrin and recombinant murine interferon-gamma on disease progression in mice infected with the polycythemia-inducing strain of the Friend virus complex.
Lu L; Shen RN; Zhou SZ; Srivastava C; Harrington M; Miyazawa K; Wu B; Lin ZH; Ruscetti S; Broxmeyer HE
Int J Hematol; 1991 Apr; 54(2):117-24. PubMed ID: 1660735
[TBL] [Abstract][Full Text] [Related]
7. Continuous replication of Friend virus complex (spleen focus-forming virus-lymphatic leukemia-inducing virus) in mouse embryo fibroblasts. Retention of leukemogenicity and loss of immunosuppressive properties.
Eckner RJ
J Exp Med; 1975 Oct; 142(4):936-48. PubMed ID: 1176891
[TBL] [Abstract][Full Text] [Related]
8. Friend virus production and heme synthesis in primary mouse spleen cell cultures.
Menna JH; Hankins WD; Kost T; Nolop K; Krantz SB
Exp Hematol; 1979 Jul; 7(6):315-23. PubMed ID: 226385
[TBL] [Abstract][Full Text] [Related]
9. Persistence and pathogenicity of defective Friend spleen focus-forming virus. Decreased transplantability of hemopoietic cells as a marker for preleukemic change.
Eckner RJ; Hettrick KL
J Exp Med; 1979 Feb; 149(2):340-57. PubMed ID: 762497
[TBL] [Abstract][Full Text] [Related]
10. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
11. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice.
Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL
J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998
[TBL] [Abstract][Full Text] [Related]
12. Loss of pathogenicity of spleen focus-forming virus after pseudotyping with Akv.
Jones KS; Ruscetti S; Lilly F
J Virol; 1988 Feb; 62(2):511-8. PubMed ID: 2826812
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of recombinant human macrophage colony-stimulating factor in combination with whole-body hyperthermia in the treatment of mice infected with the polycythemia-inducing strain of the Friend virus complex.
Lu L; Shen RN; Zhou SZ; Wu B; Kim YJ; Lin ZH; Ruscetti S; Ralph P; Broxmeyer HE
Exp Hematol; 1991 Sep; 19(8):804-9. PubMed ID: 1907925
[TBL] [Abstract][Full Text] [Related]
14. Use of in vivo infected spleen cells to study Fv-2r-mediated resistance of mice to Friend spleen focus-forming virus.
Chantratita W; Yoosook C
Leuk Res; 1982; 6(4):595-600. PubMed ID: 7144233
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
Kitagawa M; Kamisaku H; Aizawa S; Sado T
Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
[TBL] [Abstract][Full Text] [Related]
16. Expression of Friend leukemia virus and spleen focus-forming virus-specific sequences in erythroid bursts and granulocyte-macrophage colonies from spleen and marrow of mice infected with Friend leukemia virus.
Colletta G; Di Fiore PP; Fusco A; Lettieri F; Covelli A; Peschle C
Cancer Res; 1983 Feb; 43(2):598-603. PubMed ID: 6293700
[TBL] [Abstract][Full Text] [Related]
17. A classification of the murine leukemia viruses. Neutralization of pseudotypes of Friend spleen focus-forming virus by type-specific murine antisera.
Eckner RJ; Steeves RA
J Exp Med; 1972 Oct; 136(4):832-50. PubMed ID: 4341440
[TBL] [Abstract][Full Text] [Related]
18. Genotype-limited changes in platelet and erythroid kinetics in Friend-virus-infected allophenic mice.
Eldridge PW; Dewey MJ
Exp Hematol; 1986 Jun; 14(5):380-5. PubMed ID: 3709707
[TBL] [Abstract][Full Text] [Related]
19. Induction of the autonomous stage of transformation in erythroid cells infected with SFFV: helper virus is not required.
Wolff L; Tambourin P; Ruscetti S
Virology; 1986 Jul; 152(1):272-6. PubMed ID: 3012873
[TBL] [Abstract][Full Text] [Related]
20. Effect of split low dose total body irradiation on SFFV mRNA, genomic DNA and protein expression in mice infected with the Friend virus complex.
Shen RN; Lu L; Harrington MA; Srivastava C; Kim YJ; Zhou SZ; Wu B; Ruscetti S; Broxmeyer HE
Leukemia; 1991 Mar; 5(3):225-9. PubMed ID: 2013981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
